# JBT Marel share price today (JBT Marel Corporation, JBTM)

> JBT Marel Corporation's share price has risen faster than its earnings: −6.4% in a year, against −136.7% for earnings per share. JBTM · Industrials · Specialty Industrial Machinery · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/jbtm

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $118.06 (−6.4% in a year)
- P/E: 31.5× (higher than 69% of the last 4.6 years)
- Revenue (Jun 2026): $981 M (+4.9% on a year ago)
- Profit (Jun 2026): $28.0 M (+833.3% on a year ago)
- Operating margin: 8.1% (+3.0 points on a year ago)
- ROE: −1%, FY25
- ROIC: 5.7%, against a 8.0% cost of capital: −2.3 points

The main question: profits are rising, but only 51% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the JBT Marel share price today? JBT Marel Corporation's share price was $118.06 at the close on 3 November 2026. It has been falling for 7 weeks. That is 9.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $104 and $169, and at that close it sat 21% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 14 weeks running. Over the last 10 years the share price moved +89% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 31 July 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does JBT Marel pay? JBT Marel Corporation paid $0.40 per share over the last four reported quarters. The most recent declaration was $0.10 for Jun 2026. At today's price of $118.06 that is a yield of 0.34%, based on dividends already paid, not a forecast. ## Which stock lists is JBT Marel on? JBT Marel is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is JBT Marel profitable? JBT Marel Corporation earned $28.0 M of net profit in the Jun 2026 quarter, +833.3% on the same quarter a year earlier. The full FY25 year was a loss of $50.5 M. That is 2.9% of the quarter's revenue. The same quarter a year earlier earned $3.0 M. 2 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −$50.5 M (−159.1% on the year before). ## How much revenue does JBT Marel make, and is it growing? JBT Marel Corporation reported $981 M of revenue in the Jun 2026 quarter, +4.9% on the same quarter a year earlier. That is the 8th quarter in a row with growth on the year before. Over 4 years it has grown 28.3% a year on average. The last full year, FY25, came in at $3.8 B. The last four reported quarters add to $3.9 B. FY25 revenue was $3.8 B, +121.3% on the year before. Recent pace: the last four quarters grew +62.7% on average, against 28.3% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +44.9%, against +54.6% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does JBT Marel keep? JBT Marel Corporation's operating margin was 8.1% in the Jun 2026 quarter, 3.0 percentage points higher than the same quarter a year ago. Across 5 years it has been between 4.9% and 10.9%. The latest quarter is within that range. Why the margin moved: operating margin changed +3.0 percentage points on the year while gross margin changed +0.8 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is JBT Marel's profit turning into cash? Over the last 3 years, 51% of JBT Marel Corporation's reported profit came in as cash from its operations, a gap worth watching. In FY25 it brought in $342 M of operating cash against −$50.5 M of profit. After $104 M of spending on assets, $238 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does JBT Marel's cash go? JBT Marel Corporation does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $197 M on assets over the last 3 years. Averaged over those years that is 1.7% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $197 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is JBT Marel's P/E ratio, and how does it compare with its own history? JBT Marel Corporation's P/E is 31.5×, in the middle of its own history: higher than 69% of past readings. Its usual P/E (the middle reading) is 25.3×, over 4.6 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −136.7% while the price moved −6.4%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved +3.1% a year; about −40.0% a year came from earnings growth and about +43.1 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the JBT Marel business getting better or worse? JBT Marel Corporation's business is getting worse. Profit and EPS growth are shrinking: profit growth is −159.6% in the latest quarter, against +337.3% at its best in 12 quarters, with ROCE rising at 5.6%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does JBT Marel earn on its capital? JBT Marel Corporation earned a ROE of −1% in FY25. Its return on capital used (ROIC) is 2.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −1.3% net margin and 0.46× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −1.3% net margin × 0.46× asset turnover × 1.83× leverage (assets divided by equity) ≈ −1.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 5.7% − 8.0% = −2.3 percentage points. The 8.0% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 5.7% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 4.7%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does JBT Marel have too much debt? JBT Marel Corporation has total debt of $1.7 B against shareholder equity of $4.5 B as of Jun 2026, so its debt is 0.38× its equity. Year by year, that ratio went from 0.95 in FY21 to 0.44 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the JBT Marel shareholding pattern? 8.3% of JBT Marel Corporation's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 8.1 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is JBT Marel from balance-sheet trouble? For JBT Marel Corporation, the Z-score is 2.21. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.21 is in the grey area, neither clearly safe nor clearly in trouble. ## How does JBT Marel rank in its industry? 46.9 out of 100, rank 16 of 30 in Specialty Industrial Machinery, with 74% of the evidence available. JBT Marel Corporation scores 46.9 out of 100 against the 30 companies it is compared with in Specialty Industrial Machinery, ranking 16. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 25.2 + 5.3 + 9.3 + 7.1 = 46.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is JBT Marel compared with? JBT Marel ranks 16 of 30 Specialty Industrial Machinery companies on the 4-Factor Sector Score, with 46.9 out of 100. 1. [Rockwell Automation, Inc.](https://www.sectoralpha.in/us/stocks/rok) ROK · turning · Most evidence points up · 81% evidence 70.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Revenue 11.3% · Profit 24.1% · Operating margin change 3.4 points · 83% evidence Capital efficiency 19.8/25 · ROCE 23.9% · Operating margin 21% · 76% evidence Valuation 8.7/20 · P/E 45.9× · PEG 1.82 · 65% evidence Relative strength 15.0/20 · Lead over its industry 4% · Lead over S&P 500 0.9% · 1 year 19.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.2 + 19.8 + 8.7 + 15 = 70.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Nordson Corporation](https://www.sectoralpha.in/us/stocks/ndsn) NDSN · leader · Most evidence points up · 85% evidence 68.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.9/35 · Revenue 7% · Profit 22% · Operating margin change 0.3 points · 95% evidence Capital efficiency 15.9/25 · ROCE 15% · Operating margin 27.4% · 76% evidence Valuation 12.9/20 · P/E 29.9× · PEG 1.23 · 65% evidence Relative strength 19.2/20 · Lead over its industry 14% · Lead over S&P 500 10.7% · 1 year 42.3% · 100% evidence · 9 of 12 weeks ahead Exact sum: 20.9 + 15.9 + 12.9 + 19.2 = 68.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Watts Water Technologies, Inc.](https://www.sectoralpha.in/us/stocks/wts) WTS · quiet · Most evidence points up · 81% evidence 67.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 17.1% · Profit 23.1% · Operating margin change -0.6 points · 83% evidence Capital efficiency 19.0/25 · ROCE 21.4% · Operating margin 20.9% · 76% evidence Valuation 12.0/20 · P/E 31.3× · PEG 1.35 · 65% evidence Relative strength 13.7/20 · Lead over its industry 10.1% · Lead over S&P 500 6.9% · 1 year 31.9% · 100% evidence · 3 of 12 weeks ahead Exact sum: 22.3 + 19 + 12 + 13.7 = 67 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Emerson Electric Co.](https://www.sectoralpha.in/us/stocks/emr) EMR · breaking out · Evidence leans up · 81% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 4.8% · Profit 0.1% · Operating margin change 2.1 points · 83% evidence Capital efficiency 17.3/25 · ROCE 16.8% · Operating margin 26.9% · 76% evidence Valuation 10.3/20 · P/E 31.1× · PEG 1.78 · 65% evidence Relative strength 19.3/20 · Lead over its industry 12.7% · Lead over S&P 500 9.3% · 1 year 28.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 17.3 + 17.3 + 10.3 + 19.3 = 64.2 · What this means: Relative strength against the index is 9.3%, and revenue and profit growth are weak. 5. [Illinois Tool Works Inc.](https://www.sectoralpha.in/us/stocks/itw) ITW · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 4.3% · Profit -5.1% · Operating margin change 0.3 points · 83% evidence Capital efficiency 20.9/25 · ROCE 41.8% · Operating margin 26.9% · 76% evidence Valuation 10.4/20 · P/E 24.4× · PEG 1.82 · 65% evidence Relative strength 15.4/20 · Lead over its industry 5.5% · Lead over S&P 500 2.1% · 1 year 16.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 17.3 + 20.9 + 10.4 + 15.4 = 64 · What this means: Relative strength against the index is 2.1%, and revenue and profit growth are weak. 6. [Crane Company](https://www.sectoralpha.in/us/stocks/cr) CR · quiet · Evidence leans up · 81% evidence 61.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Revenue 16.3% · Profit -4.3% · Operating margin change 17.8 points · 83% evidence Capital efficiency 17.1/25 · ROCE 18.3% · Operating margin 35.5% · 76% evidence Valuation 11.8/20 · P/E 38.3× · PEG 1.24 · 65% evidence Relative strength 12.6/20 · Lead over its industry 3.8% · Lead over S&P 500 0.6% · 1 year 9.1% · 100% evidence · 2 of 12 weeks ahead Exact sum: 19.5 + 17.1 + 11.8 + 12.6 = 61 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Dover Corporation](https://www.sectoralpha.in/us/stocks/dov) DOV · turning · Evidence leans up · 85% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.1/35 · Revenue 8.2% · Profit -48.2% · Operating margin change 1 points · 95% evidence Capital efficiency 14.3/25 · ROCE 14.1% · Operating margin 19.7% · 76% evidence Valuation 16.0/20 · P/E 21.6× · PEG 0.22 · 65% evidence Relative strength 12.8/20 · Lead over its industry 1.8% · Lead over S&P 500 -1.7% · 1 year 18.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 17.1 + 14.3 + 16 + 12.8 = 60.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [GE Vernova Inc.](https://www.sectoralpha.in/us/stocks/gev) GEV · quiet · Evidence leans up · 85% evidence 58.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.6/35 · Revenue 16.9% · Profit 100% · Operating margin change 7.1 points · 95% evidence Capital efficiency 11.8/25 · ROCE 15.8% · Operating margin 12.8% · 76% evidence Valuation 7.5/20 · P/E 24.4× · PEG 2.79 · 65% evidence Relative strength 9.2/20 · Lead over its industry 2.5% · Lead over S&P 500 -0.7% · 1 year 59.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 29.6 + 11.8 + 7.5 + 9.2 = 58.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Flowserve Corporation](https://www.sectoralpha.in/us/stocks/fls) FLS · turning · Evidence leans up · 81% evidence 57.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.9/35 · Revenue -0.3% · Profit 27.4% · Operating margin change 0.6 points · 83% evidence Capital efficiency 10.6/25 · ROCE 13.2% · Operating margin 13.9% · 76% evidence Valuation 14.7/20 · P/E 25.5× · PEG 0.88 · 65% evidence Relative strength 15.2/20 · Lead over its industry 5.7% · Lead over S&P 500 2.1% · 1 year 17% · 100% evidence · 1 of 12 weeks ahead Exact sum: 16.9 + 10.6 + 14.7 + 15.2 = 57.4 · What this means: Relative strength against the index is 2.1%, and revenue and profit growth are weak. 10. [AMETEK, Inc.](https://www.sectoralpha.in/us/stocks/ame) AME · turning · Evidence leans up · 81% evidence 55.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Revenue 12.6% · Profit 9.7% · Operating margin change 0.7 points · 83% evidence Capital efficiency 15.4/25 · ROCE 14.9% · Operating margin 26.2% · 76% evidence Valuation 5.4/20 · P/E 35.2× · PEG 3.47 · 65% evidence Relative strength 14.7/20 · Lead over its industry 7.1% · Lead over S&P 500 3.8% · 1 year 26.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.4 + 15.4 + 5.4 + 14.7 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [IDEX Corporation](https://www.sectoralpha.in/us/stocks/iex) IEX · turning · Evidence leans up · 81% evidence 54.7 out of 100 Growth Capital Valuation Relative
12. [Otis Worldwide Corporation](https://www.sectoralpha.in/us/stocks/otis) OTIS · turning · Evidence leans up · 81% evidence 52.0 out of 100 Growth Capital Valuation Relative
13. [Donaldson Company, Inc.](https://www.sectoralpha.in/us/stocks/dci) DCI · quiet · Evidence leans up · 85% evidence 51.9 out of 100 Growth Capital Valuation Relative
14. [The Middleby Corporation](https://www.sectoralpha.in/us/stocks/midd) MIDD · basing · Too little evidence to rank firmly · 56% evidence 49.1 out of 100 Growth Capital Valuation Relative
15. [Parker-Hannifin Corporation](https://www.sectoralpha.in/us/stocks/ph) PH · quiet · Evidence leans down · 81% evidence 48.6 out of 100 Growth Capital Valuation Relative
16. JBT Marel Corporation this page JBTM · basing · Evidence leans down · 74% evidence 46.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.2/35 · Revenue 44.8% · Profit n/a · Operating margin change 3 points · 62% evidence Capital efficiency 5.3/25 · ROCE 5.6% · Operating margin 8.1% · 76% evidence Valuation 9.3/20 · P/E 39.3× · PEG 1.79 · 65% evidence Relative strength 7.1/20 · Lead over its industry -13% · Lead over S&P 500 -16.2% · 1 year -16.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 25.2 + 5.3 + 9.3 + 7.1 = 46.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 17. [Gates Industrial Corporation plc](https://www.sectoralpha.in/us/stocks/gtes) GTES · quiet · Evidence leans down · 81% evidence 44.7 out of 100 Growth Capital Valuation Relative
18. [Graco Inc.](https://www.sectoralpha.in/us/stocks/ggg) GGG · quiet · Evidence leans down · 85% evidence 43.5 out of 100 Growth Capital Valuation Relative
19. [A. O. Smith Corporation](https://www.sectoralpha.in/us/stocks/aos) AOS · turning · Evidence leans down · 81% evidence 43.4 out of 100 Growth Capital Valuation Relative
20. [Ingersoll Rand Inc.](https://www.sectoralpha.in/us/stocks/ir) IR · quiet · Evidence leans down · 74% evidence 43.2 out of 100 Growth Capital Valuation Relative
21. [Pentair plc](https://www.sectoralpha.in/us/stocks/pnr) PNR · turning · Evidence leans down · 81% evidence 42.9 out of 100 Growth Capital Valuation Relative
22. [Regal Rexnord Corporation](https://www.sectoralpha.in/us/stocks/rrx) RRX · turning · Evidence leans down · 81% evidence 42.6 out of 100 Growth Capital Valuation Relative
23. [ITT Inc.](https://www.sectoralpha.in/us/stocks/itt) ITT · quiet · Too little evidence to rank firmly · 58% evidence 42.3 out of 100 Growth Capital Valuation Relative
24. [Symbotic Inc.](https://www.sectoralpha.in/us/stocks/sym) SYM · basing · Evidence leans down · 64% evidence 42.2 out of 100 Growth Capital Valuation Relative
25. [Enpro Inc.](https://www.sectoralpha.in/us/stocks/npo) NPO · quiet · Evidence leans down · 81% evidence 41.3 out of 100 Growth Capital Valuation Relative
26. [Xylem Inc.](https://www.sectoralpha.in/us/stocks/xyl) XYL · basing · Evidence leans down · 81% evidence 39.9 out of 100 Growth Capital Valuation Relative
27. [Cummins Inc.](https://www.sectoralpha.in/us/stocks/cmi) CMI · basing · Evidence leans down · 81% evidence 37.3 out of 100 Growth Capital Valuation Relative
28. [Eaton Corporation plc](https://www.sectoralpha.in/us/stocks/etn) ETN · quiet · Evidence leans down · 81% evidence 37.2 out of 100 Growth Capital Valuation Relative
29. [Generac Holdings Inc.](https://www.sectoralpha.in/us/stocks/gnrc) GNRC · turning · Evidence leans down · 81% evidence 36.8 out of 100 Growth Capital Valuation Relative
30. [Chart Industries, Inc.](https://www.sectoralpha.in/us/stocks/gtls) GTLS · Too little evidence to rank firmly · 36% evidence 31.0 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Industrial Machinery](https://www.sectoralpha.in/us/sectors/specialty-industrial-machinery), all 30 compared on one page. ## Which companies are close to JBT Marel in size? JBT Marel is the 28th largest of 57 Specialty Industrial Machinery companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Donaldson Company, Inc., A. O. Smith Corporation and Gates Industrial Corporation plc. Just below it: Enpro Inc., The Middleby Corporation and Mirion Technologies, Inc. ### Specialty Industrial Machinery companies close in size

1. [Donaldson Company, Inc.](https://www.sectoralpha.in/us/stocks/dci) $10 billion
2. [A. O. Smith Corporation](https://www.sectoralpha.in/us/stocks/aos) $8.6 billion
3. [Gates Industrial Corporation plc](https://www.sectoralpha.in/us/stocks/gtes) $6.2 billion
4. JBT Marel Corporation $6.1 billion
5. [Enpro Inc.](https://www.sectoralpha.in/us/stocks/npo) $6 billion
6. [The Middleby Corporation](https://www.sectoralpha.in/us/stocks/midd) $5.6 billion
7. [Mirion Technologies, Inc.](https://www.sectoralpha.in/us/stocks/mir) $4.7 billion

[All 57 Specialty Industrial Machinery companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-industrial-machinery#all-companies)

### Companies close in size in other industries

1. [The Trade Desk, Inc.](https://www.sectoralpha.in/us/stocks/ttd) $5.9 billion · Advertising Agencies
2. [Box, Inc.](https://www.sectoralpha.in/us/stocks/box) $5.9 billion · Software - Infrastructure
3. JBT Marel Corporation $5.9 billion
4. [Dolby Laboratories, Inc.](https://www.sectoralpha.in/us/stocks/dlb) $5.9 billion · Specialty Business Services
5. [Caesars Entertainment, Inc.](https://www.sectoralpha.in/us/stocks/czr) $5.9 billion · Resorts & Casinos

## What else do people ask about JBT Marel? ### What were JBT Marel's latest quarterly results? JBT Marel Corporation reported revenue of $981 M and net profit of $28.0 M for the Jun 2026 quarter. Revenue rose 4.9% and profit rose 833.3% compared with a year earlier. Earnings per share were $0.54. The operating margin was 8.1%, 3.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is JBT Marel's market cap? JBT Marel Corporation's market capitalisation is $6.1 B at a stock price of $118.06. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is JBT Marel performing? JBT Marel Corporation's share price has been falling for 7 weeks. In its latest quarter, revenue rose 4.9% and profit rose 833.3% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 14 weeks running (as of 3 November 2026). ### Will JBT Marel's stock price go up? This page does not forecast JBT Marel Corporation's stock price. What it shows instead: the stock price is $118.06, and it has been falling for 7 weeks. Its P/E of 31.5× is higher than 69% of its own last 5 years (as of 3 November 2026). ### Where is JBT Marel in its business cycle? JBT Marel Corporation's FY25 operating margin was 4.9%, against a 5-year range of 4.9% to 10.9%: the low end of its own range, which is often where recoveries start. The latest quarter was 8.1%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the JBT Marel story? The main question: profits are rising, but only 51% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is JBT Marel a stock worth studying right now? What the numbers show: JBT Marel Corporation's share price has risen faster than its earnings: −6.4% in a year, against −136.7% for earnings per share. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.